National Bank of Canada’s Petros Pharmaceuticals PTPI Stock Holding History

National Bank of Canada’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8	Closed	-$14	–	3182
2025 Q1	$14	Hold	8	–	–	﹤0.01%	2787
2024 Q4	$79	Sell	8 -5	-38%	-$41	﹤0.01%	2811
2024 Q3	$112	Hold	13	–	–	﹤0.01%	2554
2024 Q2	$136	Hold	13	–	–	﹤0.01%	2621
2024 Q1	$198	Buy	+13	New	+$458	﹤0.01%	2638

National Bank of Canada's PTPI Position: Q2 2025 in Review

National Bank of Canada sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 8 shares — an estimated $14 sold.

National Bank of Canada first reported a position in PTPI in Q1 2024 and held it in 5 quarters. The position peaked at $198 in Q1 2024. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.

National Bank of Canada reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
National Bank of Canada sold 8 Petros Pharmaceuticals shares in Q2 2025, an estimated $14.
National Bank of Canada first reported a position in Petros Pharmaceuticals in Q1 2024 and held it in 5 quarters.
National Bank of Canada's Petros Pharmaceuticals position peaked at $198 in Q1 2024.
0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.